Delivery Order SPE2DU25D8003-SPE2DU26F0F02

Cardinal Health, Inc., a global healthcare services and products company headquartered in Dublin, Ohio, was awarded a delivery order valued at $1,519.00 under the Defense Logistics Agency's Pharmaceutical Prime Vendor Fleet program on November 29, 2025. This firm fixed-price delivery order, with an ultimate completion date of December 1, 2025, represents a small-value procurement supporting the Department of Defense's medical supply requirements through the DLA's established pharmaceutical vendor network. The award carries no set-aside designation and was issued on an unrestricted, full and open competition basis. Cardinal Health has established itself as a critical supplier of specialized medical products and pharmaceuticals to federal government agencies, with particular expertise in radiopharmaceuticals, advanced medical devices, and specialty pharmaceutical products.

The delivery order is executed under the broader Pharmaceutical Prime Vendor Fleet vehicle, which enables the Defense Logistics Agency to efficiently procure pharmaceutical and medical products for military medical treatment facilities and Department of Defense healthcare operations. Cardinal Health's role within this program reflects its extensive federal contracting portfolio, which encompasses supply chain management across multiple service networks and subsidiaries including Cardinal Health 414 LLC (radiopharmaceuticals), Cardinal Health 108 LLC (specialty pharmaceuticals), Biosense Webster Inc. (cardiac electrophysiology devices), and Wavemark Inc. (RFID-based inventory management systems). The company's federal contract awards total millions of dollars across multiple contract vehicles and funding sources, supporting healthcare delivery requirements for the Department of Veterans Affairs, Department of Defense, National Institutes of Health, and other federal agencies.